Archive ready

新型コロナウイルスワクチンの特例承認について｜厚生労働省

https://www.mhlw.go.jp/stf/newpage_28919.html

April 10, 2026 at 09:01 AM JST•The archive page, viewer, and downloads use this saved version.

April 10, 2026 at 09:01 AM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

新型コロナウイルスワクチンの特例承認について｜厚生労働省

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.mhlw.go.jp/stf/newpage_28919.html

StartedApril 10, 2026 at 09:01 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page announces the special approval by Japan's Ministry of Health, Labour and Welfare for partial changes to the approval of Spikevax intramuscular injection. A bivalent vaccine containing mRNA encoding spike proteins of the original strain and Omicron BA.4-5 has been added. The approval was based on an application from Moderna Japan submitted on October 5, 2022. The document details dosage, administration methods, and vaccination intervals. The vaccine is approved for preventing SARS-CoV-2 infection.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.